Vertex Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VRTX

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. 

CEO
Reshma Kewalramani
CEOReshma Kewalramani
Employees
6,400
Employees6,400
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
1989
Founded1989
Employees
6,400
Employees6,400

VRTX Key Statistics

Market cap
114.62B
Market cap114.62B
Price-Earnings ratio
27.21
Price-Earnings ratio27.21
Dividend yield
Dividend yield
Average volume
1.27M
Average volume1.27M
High today
$464.98
High today$464.98
Low today
$450.40
Low today$450.40
Open price
$461.26
Open price$461.26
Volume
2.97M
Volume2.97M
52 Week high
$507.92
52 Week high$507.92
52 Week low
$362.50
52 Week low$362.50

Stock Snapshot

As of today, Vertex Pharmaceuticals(VRTX) shares are valued at $452.15. The company's market cap stands at 114.62B, with a P/E ratio of 27.21.

As of 2026-06-18, Vertex Pharmaceuticals(VRTX) stock has fluctuated between $450.40 and $464.98. The current price stands at $452.15, placing the stock +0.4% above today's low and -2.8% off the high.

The Vertex Pharmaceuticals(VRTX)'s current trading volume is 2.97M, compared to an average daily volume of 1.27M.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $507.92 at its peak.

During the past year, Vertex Pharmaceuticals(VRTX) stock moved between $362.50 at its lowest and $507.92 at its peak.

VRTX News

The Motley Fool 1d
The Best Biotech Stocks to Buy in 2026 - The Motley Fool

...

The Best Biotech Stocks to Buy in 2026 - The Motley Fool
Simply Wall St 6d
What Vertex Pharmaceuticals's Pediatric CF and Kidney Disease Data Means For Shareholders

Vertex Pharmaceuticals recently reported Phase 3 data showing that ALYFTREK improved cystic fibrosis transmembrane conductance regulator function in children ag...

What Vertex Pharmaceuticals's Pediatric CF and Kidney Disease Data Means For Shareholders

Analyst ratings

81%

of 36 ratings
Buy
80.6%
Hold
16.7%
Sell
2.8%

People also own

Based on the portfolios of people who own VRTX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.